The O-glycosylation of mucin-type molecules is responsible for their unique physicochemical properties. Despite the fact that O- glycosylation is ubiquitous, little is known about the way it is regulated. We are studying the initiation of glycosylation by UDP- N-acetylgalactosamine:peptide N-acetylgalactosamine transferase. We have formed an extensive database of known glycosylated sites and their flanking sequences. Computer analysis of the amino acid sequences surrounding glycosylated site does not reveal a strict consensus, but suggests that sequence may influence the initiation of O-glycosylation, particularly at positions -1 and +3, relative to the glycosylated site. A series of test peptides was made to experimentally verify this hypothesis. It was found that single amino acid changes at the 'sensitive' positions near a threonine residue could dramatically alter its ability to be glycosylated. Furthermore, circular dichroism spectroscopy showed that all the substrates that were glycosylated had random-type structure. A set of 50 peptides has been synthesized to extend the investigation of flanking sequences. Serine-containing substrates glycosylate poorly compared to those containing threonine. GalNAc transferase was partially purified from a number of rat, human and bovine tissue. Assays of serine- containing peptides reveals that their inability to be glycosylated in vitro is not due to flanking sequence alone.. We have suggested that a separate GalNAc transferase is responsible for glycosylating serine, and are currently attempting to isolate this activity. It seems possible that a family of GalNAc transferases exists, having multiple overlapping sequence specificities. This would explain the absence of a single consensus sequence for all glycosylated sites. Future studies, involving the design and production of recombinant mucin-like species (eg for replacement therapy in salivary hypofunction) will have to take into account both substrate sequence requirements and enzyme activities available to successfully facilitate their glycosylation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Unknown (K16)
Project #
5K16DE000159-08
Application #
3839117
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
8
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Rochester
Department
Type
DUNS #
208469486
City
Rochester
State
NY
Country
United States
Zip Code
14627
Howard, E W; Newman, L A; Oleksyn, D W et al. (2001) SpKrl: a direct target of beta-catenin regulation required for endoderm differentiation in sea urchin embryos. Development 128:365-75
Caldwell, C E; Marquis, R E (1999) Oxygen metabolism by Treponema denticola. Oral Microbiol Immunol 14:66-72
New, D R; Ma, M; Epstein, L G et al. (1997) Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. J Neurovirol 3:168-73
Kaplan, M D; Olschowka, J A; O'Banion, M K (1997) Cyclooxygenase-1 behaves as a delayed response gene in PC12 cells differentiated by nerve growth factor. J Biol Chem 272:18534-7
O'Banion, M K; Miller, J C; Chang, J W et al. (1996) Interleukin-1 beta induces prostaglandin G/H synthase-2 (cyclooxygenase-2) in primary murine astrocyte cultures. J Neurochem 66:2532-40
Madden, T E; Clark, V L; Kuramitsu, H K (1995) Revised sequence of the Porphyromonas gingivalis prtT cysteine protease/hemagglutinin gene: homology with streptococcal pyrogenic exotoxin B/streptococcal proteinase. Infect Immun 63:238-47
O'Connell, B C; Tabak, L A (1993) Separation of glycopeptides from in vitro O-glycosylation reactions using C18 cartridges. Anal Biochem 210:423-5
O'Connell, B C; Tabak, L A (1993) A comparison of serine and threonine O-glycosylation by UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase. J Dent Res 72:1554-8
O'Connell, B C; Hagen, F K; Tabak, L A (1992) The influence of flanking sequence on the O-glycosylation of threonine in vitro. J Biol Chem 267:25010-8
Madden, T E; Thompson, T M; Clark, V L (1992) Expression of Porphyromonas gingivalis proteolytic activity in Escherichia coli. Oral Microbiol Immunol 7:349-56

Showing the most recent 10 out of 22 publications